Antithrombin Deficiency - Description, Causes and Risk Factors:
A plasma alpha2-globulin process that inhibits thrombin and has anticoagulant activities. Deficiency is commonly inherited as an autosomal dominant trait, caused by mutation in antithrombin III gene (AT3) or chromosome 1q; this is one of the few known mendelizing disorders from which thrombotic disease occurs.
Antithrombin is a protein that prevents too much blood clotting. Antithrombin deficiency is an inherited disorder that results in a lower level than normal of antithrombin in the blood. Antithrombin deficiency is rare, occurring in about 1 in 1000 people in the United States. Antithrombin deficiency can be inherited from one or both parents. This means that if one parent has it, then each child has a 50:50 chance of inheriting it. In some cases, antithrombin III deficiency may be acquired as a result of kidney or liver disease.
There is normally a careful balance of enzymes in the bloodstream; enzymes such as thrombin and factor X prevent the blood from becoming too thin, and chemicals such as antithrombin III and heparin prevent the blood from thickening. In the case of an antithrombin deficiency, coagulating enzymes prosper and the risk of clotting is high. In rare cases, patients may develop antithrombin deficiency as the result of some more serious underlying health condition, including:
- Kidney failure.
- Liver disease.
- Nephrotic syndrome.
- Physical trauma.
- Systemic lupus erythematosus (SLE).
- Truncus arteriosus.
- Atrial septal defect.
- Ventricular septal defect.
- Bone marrow transplants.
- Medication that increases coagulation activity.
- Medication that inhibits protein development.
Symptoms of Antithrombin Deficiency:
Patients will usually have symptoms of a blood clot, including:
- Coughing up blood.
- Chest pain.
- Shortness of breath and pain when taking deep breaths.
- Swelling of one leg.
A physical examination may show:
- Abnormal lung sounds.
- Fast breathing.
- Fast heart rate.
- Swollen foot or leg.
The diagnosis of antithrombin deficiency is made by a blood test that measures the amount of antithrombin in the blood. This test is usually performed in a Specialized laboratory.
Prothrombin time (PT) and activated partial thromboplastin time (aPTT): These studies allow evaluation of the presence of inappropriate activation of the Coagulation system.
- Protein C or protein S deficiencies are both associated with venous thrombosis and are important exclusions in evaluating congenital deficiency of antithrombin.
- The most common congenital procoagulant disorder, factor V Leiden, occurs in about 5% of patients and needs to be documented when attempting to make the diagnosis of congenital antithrombin deficiency. Knowing this level also helps to define a given patient's procoagulant risk.
- Anticardiolipin antibodies (both immunoglobulin G [IgG] and immunoglobulin M [IgM] class): These should be measured by enzyme-linked immunosorbent assay (ELISA) or other physical means to rule out coexisting thrombotic risk from this source.
The primary goal of treatment is to prevent blood clots. The treatment you receive will depend on your history of previous blood clots, overall health, symptoms, and need for other medications or surgical procedures. The duration of treatment will vary depending on your individual medical history, and the presence of other health problems. Your treatment plan should be discussed with your Primary doctor or Hematologist. Some people with thrombophilia will never need treatment. Your doctor may recommend treatment with anticoagulant medications (blood thinners), such as heparin, low-molecular weight heparin, or warfarin to help prevent blood clots.
NOTE: The above information is educational purpose. The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition.
DISCLAIMER: This information should not substitute for seeking responsible, professional medical care.
A large-scale scientific review, presented at the European Association for the Study of Diabetes meeting in Berlin, suggests that three to four cups of coffee a day may decrease the risk of developing type 2 diabetes by 25 percent. For the study, the researchers...
A new study, recently published in the European Journal of Preventive Cardiology, suggests that exposure to blue light may help reduce high blood pressure. For the study, a team of researchers assessed whether blue light exposure could produce enough nitric oxide to...
Factors such as age, gender, physical activity, genetics, medical history, body type, and others directly affect not only the desire to lose weight, but also to follow the right diet. Everything is relative, everything is individual. Nevertheless, there are universal...read more
It is very entertaining to be a sport fan. There is a big variety of sport games that are extremely interesting to follow. Moreover, it is always fun to anticipate the score and watch the enthusiasm live. One of the benefits of being sports fan is using different...read more
A new study of nearly 18,000 participants found that those with high fitness at middle age were significantly less likely to die from heart disease in later life, even if they were diagnosed with depression. Doctor's Tips: How to Stay Fit While Treating Depression Dr....read more